RecordatiIT0003828271RECREC
There is no discussion about the security yet. Share your thoughts now!
Financials
Market Cap
$11.76B5Y beta
0.30EPS (TTM)
$1.991Free Float
97.98MP/E ratio (TTM)
28.24Revenue (TTM)
$2.48BEBITDA (TTM)
$838.94MFree Cashflow (TTM)
-$149.39MPricing
Analyst Ratings
The price target is $58.61 and the stock is covered by 11 analysts.
Buy
4
Hold
5
Sell
2
Information
Recordati Industria Chimica e Farmaceutica SpA is an Italy-based group engaged in the research, development, manufacture and marketing of pharmaceuticals. It promotes a wide range of pharmaceuticals, both proprietary and under license, in a number of therapeutic areas, such as Antibiotics and Antiviral, Cardiovascular, Central nervous system, Dermatological, Gastroenterology, Genital-urinary system, Muscular-skeletal disorders and pain therapy, Obstetrics and Gynecology and over the counter (OTC) pharmaceuticals. The Company is engaged in the research and development of new drug entities within the cardiovascular and urogenital therapeutic areas and of treatments for rare diseases. It’s product is ZANIDIP, a latest generation calcium-channel blocker for the treatment hypertension. It operates through Italchimici SpA, Pro Farma AG and North American marketing rights to Cystadane. The Company owns and operates through Natural Point srl also in the food supplement sector.